<DOC>
	<DOCNO>NCT02171806</DOCNO>
	<brief_summary>To investigate safety , tolerability , pharmacokinetics pharmacodynamics BI 1744 CL</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics Pharmacodynamics Study BI 1744 CL Healthy Male Female Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Olodaterol</mesh_term>
	<criteria>Healthy male female base upon complete medical history , include physical examination , regard vital sign ( blood pressure ( BP ) , pulse rate ( PR ) ) , 12lead ECG measurement , clinical laboratory test . There find deviate normal clinical relevance . There evidence clinically relevant concomitant disease . Age ≥21 ≤50 year BMI ≥18.5 &lt; 30 kg/m2 ( Body Mass Index ) Signed date write informed consent prior admission study accordance Good Clinical Practice local legislation Any finding medical examination ( include BP , PR , ECG measurement ) deviate normal clinical relevance Evidence clinically relevant concomitant disease Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder History relevant orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History relevant allergy/hypersensitivity ( include allergy drug excipients ) judge clinically relevant investigator Intake drug long halflife ( &gt; 24 hour ) within least 1 month less 10 halflives respective drug prior randomisation Use drug might reasonably influence result trial base knowledge time protocol preparation within 10 day prior randomisation Participation another trial investigational drug within 2 month prior randomisation Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Inability refrain smoke trial day judge investigator Alcohol abuse ( 60 g alcohol day ) Drug abuse Blood donation ( 100 mL blood within 4 week prior randomisation trial ) Excessive physical activity within 1 week prior randomisation trial Any laboratory value outside reference range clinical relevance Inability comply dietary regimen study centre The following exclusion criterion specific study due know class side effect profile ß2mimetics : Asthma history pulmonary hyperreactivity Hyperthyrosis Allergic rhinitis need treatment Clinically relevant cardiac arrhythmia Paroxysmal tachycardia ( &gt; 100 beat per minute ) . For female subject : Pregnancy Positive pregnancy test No adequate contraception e.g . oral contraception , sterilisation , IUD ( intrauterine device ) . Females surgically sterile ask additionally use barrier contraception method ( e.g . condom ) prior administration study medication , study least 2 month release study . Inability maintain adequate contraception whole study period Lactation period</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>